Vantage Oncology Enters Definitive Agreement To Be Acquired By McKesson

MANHATTAN BEACH, Calif., Feb. 25, 2016 /PRNewswire/ -- Vantage Oncology, LLC is pleased to announce that the company has entered into a definitive agreement to be acquired by McKesson Specialty Health, a business unit of the McKesson Corporation. Vantage is a leading national provider of radiation oncology, medical oncology, and other value-based integrated cancer care services.

McKesson Corporation, currently ranked 11th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.

"We are excited about what Vantage can accomplish as part of the McKesson platform," said Michael Fiore, chief executive officer and co-founder of Vantage. "This combination brings together two highly complementary organizations with closely aligned goals and values.  By joining together, we will be able to offer an exceptionally broad set of services to patients and physicians, and strengthen our leadership in community-based oncology and value-based cancer care."

As part of McKesson Specialty Health, Vantage Oncology, along with The US Oncology Network, will provide oncology practices a best-in-class platform and a robust suite of offerings and services that can be tailored to meet each patient's needs, allowing providers to focus on delivering the highest quality care and best outcomes at the lowest possible cost.

Following the close of the transaction, Vantage will become part of McKesson's Specialty Health business. Vantage will continue to operate independently until close.

About Vantage  
Founded in October 2002, Manhattan Beach, California-based Vantage Oncology, LLC is a leading national provider of radiation oncology, medical oncology and other value-based integrated cancer care services. The company's founding principles were to address the growing need among cancer patients, hospitals and physicians for accessible and advanced cancer treatments. Vantage currently operates 50 treatment facilities in 13 states. For more information about Vantage, visit www.vantageoncology.com.

Vantage Contacts:

James David / Kathleen Pierre
Kekst
212.521.4800
[email protected] / [email protected]

SOURCE Vantage Oncology

Related Links

http://www.vantageoncology.com